Mona has more than 42 years of experience in outcomes research, instrument development and cross-cultural applications. She has been a part of the development teams for a variety of published quality of life measures, including the I-QOL, IBSQOL, OWL-QOL, the WHOQOL. Her work includes a variety of COAs now approved as endpoints by the FDA, including the Psoriasis Symptom Inventory (PSI) and the two recently qualified instruments with the C-Path PRO Consortium (NSCLC-SAQ and SMDDS). She has helped to develop measures and explore research questions across numerous therapeutic areas including several rare diseases and those with compromised communication skills.
Prior to joining Evidera, Mona was one of the founding partners and Executive Director of Health Research Associates. She earned her nursing degree and her MPA from the University of Kentucky, she launched her research career at the University of Washington in 1986, spending the following 9 years in research methodology and instrument development for CDC funded health promotion programs.
Mona is a long-standing member of the International Society for Quality of Life Research (ISOQOL), and past co-chair of the ISOQOL TCA-SIG. As a member of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) she participated in the ISPOR task force on content validity which published the two key consensus papers. She has more than 80 published manuscripts in the area of patient centered research and is a reviewer for several professional journals.